Mitsubishi UFJ Trust & Banking Corp

Position in EXEL — Exelixis, Inc.

CIK 1462160 TOKYO, M0

Position in EXEL

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$10,739,956

-$1,111,500 QoQ

Shares Held

250,407

-7.4% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 20.953487721988605.ToString("F0")% Shared 0.ToString("F0")% None 79.04651227801139.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mitsubishi UFJ Trust & Banking Corp holds $300,915,992 across 16 Biotechnology names. EXEL ranks #8 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	166,903	$74,528,864
2	RPRX	Royalty Pharma plc	1,494,475	$71,689,965
3	REGN	Regeneron Pharmaceuticals, Inc.	50,755	$39,215,342
4	INCY	Incyte Corp	359,761	$33,860,704
5	ALNY	Alnylam Pharmaceuticals, Inc.	72,777	$24,079,724
6	MRNA	Moderna, Inc.	340,902	$17,317,821
7	INSM	INSMED Inc	84,184	$13,765,767
8	EXEL	Exelixis, Inc. This page	250,407	$10,739,956

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,739,956	250,407	-7.4%	Shares	Defined	2026-05-12
2025-12-31	$11,851,456	270,396	-4.4%	Shares	Defined	2026-01-30
2025-09-30	$11,677,203	282,741	+20.6%	Shares	Defined	2025-10-31
2025-06-30	$10,338,213	234,533	+107.2%	Shares	Defined	2025-08-08
2025-03-31	$4,179,159	113,195	+23.0%	Shares	Defined	2025-05-09
2024-12-31	$3,063,899	92,009	-3.8%	Shares	Defined	2025-02-12
2024-09-30	$2,482,532	95,666	+33.7%	Shares	Defined	2024-11-12
2024-06-30	$1,607,638	71,546	+39.4%	Shares	Defined	2024-08-08
2024-03-31	$1,218,108	51,332	+205.1%	Shares	Defined	2024-05-10
2022-12-31	$269,873	16,825	+10.9%	Shares	Defined	2023-02-10
2022-09-30	$237,865	15,170	—	Shares	Defined	2022-11-10
No filing history on record for this holder in this stock.